Inventor · disambiguated record
Sergei Gulnik
Also filed as: GULNIK SERGEI · GULNIK SERGEI V
14 granted patents·12 pending applications·73 citations·filing 1996–2024
90Inventor score
Files withBECKMAN COULTER INC12SEQUOIA PHARMACEUTICALS INC4US HEALTH3ERICKSON JOHN W2SEQUOIA PHARMACEUTICALS2
Top patents by PatentIndex Score
26 records- 0193US12018117B2Polymer dye modification and applicationsBECKMAN COULTER INC·Filed 2023·Granted Jun 25, 2024·1 cites·24 claims
- 0293US11584825B2Polymer dye modification and applicationsBECKMAN COULTER INC·Filed 2019·Granted Feb 21, 2023·5 cites·15 claims
- 0391US11208527B2Photoactive macromolecules and uses thereofBECKMAN COULTER INC·Filed 2017·Granted Dec 28, 2021·6 cites·22 claims
- 0489US11834551B2Photoactive macromolecules and uses thereofBECKMAN COULTER INC·Filed 2022·Granted Dec 5, 2023·1 cites·26 claims
- 0583US2024301131A1Polymer dye modification and applicationsBECKMAN COULTER INC·Filed 2024·Application pending·0 cites
- 0682US12312437B2Photoactive macromolecules and uses thereofBECKMAN COULTER INC·Filed 2023·Granted May 27, 2025·0 cites·28 claims
- 0780US7109230B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2003·Granted Sep 19, 2006·9 cites·26 claims
- 0879US7285566B2Resistance-repellent retroviral protease inhibitorsERICKSON JOHN W·Filed 2003·Granted Oct 23, 2007·8 cites·27 claims
- 0978US8597876B2Method of treating HIV infectionERICKSON JOHN W·Filed 2007·Granted Dec 3, 2013·3 cites·57 claims
- 1066US5849691APeptidomimetic inhibitors of cathepsin D and plasmepsins I and IIUS HEALTH·Filed 1996·Granted Dec 15, 1998·27 cites·10 claims
- 1166US2006258737A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1263US2010009935A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 1361US2006293286A1Resistant-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1460US2023399565A1Polymer dyes and uses thereofBECKMAN COULTER INC·Filed 2023·Application pending·0 cites
- 1559US2024400893A1Water-soluble tetrahydropyrene based fluorescent polymersBECKMAN COULTER INC·Filed 2022·Application pending·0 cites
- 1658US9889115B2Fitness assay and associated methodsUS HEALTH·Filed 2013·Granted Feb 13, 2018·0 cites·6 claims
- 1758US7470506B1Fitness assay and associated methodsUS HEALTH·Filed 1999·Granted Dec 30, 2008·10 cites·9 claims
- 1858US2024270971A1Uv-absorbing polymers, compositions and uses thereofBECKMAN COULTER INC·Filed 2022·Application pending·0 cites
- 1956US7320878B2Protease assay for therapeutic drug monitoringTIBOTEC PHARM LTD·Filed 2002·Granted Jan 22, 2008·3 cites·16 claims
- 2056US2005158713A1Fitness assay and associated methodsUNIV ILLINOIS·Filed 2005·Application pending·0 cites
- 2156US2024125773A1Compositions and methods for preventing non-specific interactions between polymer dyes-antibody conjugatesBECKMAN COULTER INC·Filed 2022·Application pending·0 cites
- 2250US10073082B2Proteasome inhibition assay and methods of useUNIV HEALTH NETWORK·Filed 2014·Granted Sep 11, 2018·0 cites·22 claims
- 2346US11531034B2Compositions and methods for lysis of red blood cellsBECKMAN COULTER INC·Filed 2018·Granted Dec 20, 2022·0 cites·12 claims
- 2446US2007207952A1Long Acting Biologically Active ConjugatesSEQUOIA PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 2540US2015284352A1Methods for inhibiting drug degradationSEQUOIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2632US2019079094A1Subcellular localization of target analytesBECKMAN COULTER INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →